Status:
TERMINATED
OCT-AF Imaging of Pre-cancers of Vulva and Cervix
Lead Sponsor:
British Columbia Cancer Agency
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Cervical Dysplasia
Vulvar Dysplasia
Eligibility:
FEMALE
18+ years
Brief Summary
The multimodal imaging technology, OCT-AFI, will be used to image sites on the cervix, the endocervical canal and vulva. The imaging probe is small enough, it can be inserted into the endocervical can...
Detailed Description
The multimodal optical imaging technology, OCT-AFI, has demonstrated the ability to image the small peripheral airways of the lung, allowing for high resolution of structural and functional details of...
Eligibility Criteria
Inclusion
- indicates understanding of study
- provides informed consent to participate
- 18 years or older
- not pregnant and have negative urine pregnancy test
- be scheduled for initial visit colposcopy for cervix or vulva or LEEP (loop electrosurgical excision procedure) for treatment of abnormalities on cervix at the Women's Clinic at Vancouver General Hospital (VGH)
Exclusion
- breastfeeding
Key Trial Info
Start Date :
July 25 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03285841
Start Date
July 25 2019
End Date
December 30 2020
Last Update
March 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vancouver General Hospital Women's Clinic
Vancouver, British Columbia, Canada, V5Z 1M9